Table 2.
Cost per patient receiving schizophrenia treatment, according to the category of procedure during the follow-up period. Brazil, 2000–2010 (n = 174,310)
| Category of procedure | Patients, N (%) | Cost ($US) | ||
|---|---|---|---|---|
| Meana (SD) | Medianb (IQR 1; IQR 3) | %c | ||
| Atypical antipsychotics | 174,310 (100.0) | 1578.74 (240.40) | 1235.86 (1001.12; 1341.90) | 79.7 |
| Outpatient psychiatric care | 30,292 (17.4) | 862.96 (160.18) | 396.52 (342.01; 420.31) | 6.0 |
| Psychiatric hospitalization | 19,212 (11.0) | 2482.90 (302.92) | 1313.94 (1283.82; 1344.95) | 5.6 |
| Other high-cost drugs | 26,820 (15.4) | 924.04 (151.07) | 272.58 (189.00; 537.54) | 5.2 |
| Other hospitalizations | 20,834 (12.0) | 1266.99 (201.58) | 450.07 (420.17; 453.16) | 2.2 |
| Other outpatient care | 31,330 (18.0) | 345.75 (35.80) | 50.32 (39.75; 63.52) | 1.2 |
Values were converted to $US and adjusted using the purchasing power parity rate (World Bank)
IQR interquartile range, SD standard deviation
aMean annual cost per patient
bMedian annual cost per patient
cProportion of total costs